Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Mutiple myeloma treatment in the non-transplant setting

Dr Sonia Zweegman, Prof Marivi Mateos
Mutiple myeloma treatment in the non-transplant setting ( Dr Sonia Zweegman, Prof Marivi Mateos )
3 Apr 2013

Relapse and retreatment of multiple myeloma

Prof Heinz Ludwig, Dr Sergio Giralt
Relapse and retreatment of multiple myeloma ( Prof Heinz Ludwig, Dr Sergio Giralt )
3 Apr 2013

New data in the diagnosis and prognosis of multiple myeloma

Prof Paul Richardson, Prof Phillippe Moreau, Prof Jesus San Miguel, Prof Gareth Morgan
New data in the diagnosis and prognosis of multiple myeloma ( Prof Paul Richardson, Prof Phillippe Moreau, Prof Jesus San Miguel, Prof Gareth Morgan )
3 Apr 2013

Expert Panel: Anaemia, neutropenia, thrombocytopenia and cancer

Prof Matti Aapro, Prof Mario Dicato, Prof Pere Gascón, Prof Heinz Ludwig
Expert Panel: Anaemia, neutropenia, thrombocytopenia and cancer ( Prof Matti Aapro, Prof Mario Dicato, Prof Pere Gascón, Prof Heinz Ludwig )
18 Mar 2013

ASCO GU: Current thinking in mCRPC

Dr Howard Scher - Memorial Sloan Kettering Cancer Center, New York
ASCO GU: Current thinking in mCRPC ( Dr Howard Scher - Memorial Sloan Kettering Cancer Center, New York )
1 Mar 2013

Overtreatment of low risk prostate cancer: incidence in USA, cost, complications and implications

Dr Ayal Aizer - Dana Farber Cancer Centre, Boston, USA
Overtreatment of low risk prostate cancer: incidence in USA, cost, complications and implications ( Dr Ayal Aizer - Dana Farber Cancer Centre, Boston, USA )
26 Feb 2013

Effect of therapeutic anticoagulation on overall survival in men receiving docetaxel for mCRPC

Dr Caroline Pratz - Kimmel Cancer Center, Johns Hopkins University, Baltimore
Effect of therapeutic anticoagulation on overall survival in men receiving docetaxel for mCRPC ( Dr Caroline Pratz - Kimmel Cancer Center, Johns Hopkins University, Baltimore )
25 Feb 2013

Enzalutamide monotherapy: Phase II study results in patients with hormone-naive prostate cancer

Dr Bertrand Tombal - Catholic University of Louvain, Belgium
Enzalutamide monotherapy: Phase II study results in patients with hormone-naive prostate cancer ( Dr Bertrand Tombal - Catholic University of Louvain, Belgium )
25 Feb 2013

Gleason upgrading with time in a large, active surveillance cohort with long-term follow-up

Dr Andrew Loblaw - Sunnybrook Health Sciences Centre, Toronto, Canada
Gleason upgrading with time in a large, active surveillance cohort with long-term follow-up ( Dr Andrew Loblaw - Sunnybrook Health Sciences Centre, Toronto, Canada )
25 Feb 2013

Pelvic radiotherapy and androgen blockade for high risk prostate cancer

Dr Abdenour Nabid - Sherbrooke University, Quebec, Canada
Pelvic radiotherapy and androgen blockade for high risk prostate cancer ( Dr Abdenour Nabid - Sherbrooke University, Quebec, Canada )
25 Feb 2013

TIVO 1 study shows tivozanib an option for renal cell carcinoma

Dr Robert Motzer - Memorial Sloan Kettering Cancer Centre, New York, USA
TIVO 1 study shows tivozanib an option for renal cell carcinoma ( Dr Robert  Motzer - Memorial Sloan Kettering Cancer Centre, New York, USA )
25 Feb 2013

Chemo-radiotherapy for bladder cancer

Prof Nick James - University of Birmingham, UK
Chemo-radiotherapy for bladder cancer ( Prof Nick James	 - University of Birmingham, UK )
25 Feb 2013